Radiotherapy Plan Evaluation Using Multivariate Dose and LET Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing radiotherapy treatment plans fail to consider the interactive effects of multiple factors such as dose, Linear Energy Transfer (LET), and other metrics, leading to suboptimal treatment outcomes.
Innovation Solution
A computer-based method for evaluating radiotherapy treatment plans by simulating delivery, obtaining multiple metrics, performing multivariate analysis, and visualizing their relationships in 2D/3D histograms to determine plan quality and guide improvements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple metrics (dose, LET, RBE, etc.) are considered together in evaluation, then the accuracy and comprehensiveness of treatment plan assessment is improved, but the complexity of the evaluation system increases
Solution Approach 1:
The patent combines multiple metrics (dose, LET, RBE, dose rate, track-ends, statistical uncertainty, alpha/beta ratio) into a unified multivariate analysis framework. This merging of previously separate evaluation parameters allows comprehensive assessment of treatment plan quality while accounting for interactions between metrics, resolving the contradiction by integrating complexity into a cohesive system that improves evaluation accuracy.
Solution Approach 2:
The patent transitions from univariate or bivariate analysis to multivariate analysis, adding dimensions to the evaluation space. By visualizing relationships between multiple metrics simultaneously (e.g., using 3D surfaces or heat maps with multiple variables), the system captures complex interactions that would be invisible in lower-dimensional analyses, thereby improving evaluation comprehensiveness while managing system complexity through structured multidimensional visualization.
2Loss of information
If multivariate analysis is performed to consider interactions between metrics, then the understanding of treatment effects is improved, but the computational resources and time required increase
Solution Approach 1:
The patent performs simulations to obtain values for all relevant metrics before conducting the multivariate analysis. By preparing and organizing the data for multiple metrics (dose, LET, RBE, etc.) in advance, the system enables efficient multivariate analysis without excessive computational overhead during the actual evaluation phase, thus reducing information loss while managing time requirements.
3Manufacturing precision
If detailed multivariate analysis with multiple metrics is conducted, then the quality assessment of treatment plans is improved, but the ease of operation and interpretation decreases
Solution Approach 1:
The patent employs heat maps and color-coded visualizations to represent the relationships between multiple metrics. Different color intensities and patterns indicate the strength and nature of interactions between metrics (e.g., dose-LET relationships), allowing clinicians to quickly interpret complex multivariate data without requiring deep analytical expertise, thus maintaining high assessment quality while improving ease of operation.
Solution Approach 2:
The patent uses 3D surface plots and multidimensional visualizations to display relationships between multiple metrics simultaneously. By adding visual dimensions (such as color, height, or density layers), the system encodes multiple variables in a single intuitive graphic, enabling comprehensive quality assessment while keeping the interface interpretable for clinical users.
Data Source
Figure 1a~2a
Figure 2b~2c
Figure 3~4
AI summary
A radiotherapy treatment plan may be evaluated based on a combination of two or more metrics, by the steps of simulating the result of delivery of the plan, obtaining values from the simulation for at least a first and a second metric, performing a multivariate analysis of the values and determining a quality of the plan based on the result of the multivariate analysis. The metrics may include at least one of dose, LET, track ends, RBE, alpha/beta ratio and statistical uncertainty of the plan.